Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyotrophic Lateral Sclerosis.

Demaerschalk1, Strong

  • 1Room 7OF10, University Campus, London Health Sciences Centre, 339 Windermere Road, London, Ontario N6A 5A5, Canada.

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two Fatal Cases of Chronic Nephritis.

Canadian Medical Association journal·2010
Same author

When is a trophic cascade a trophic cascade?

Trends in ecology & evolution·2000
Same author

Conclusion: pediatric cardiology exercise testing

Pediatric cardiology·1998
Same author

Field Theories for Learning Probability Distributions.

Physical review letters·1996
Same author

Coherence and Localization in 2D Luttinger Liquids.

Physical review letters·1996
Same author

New types of off-diagonal long range order in quantum spin chains.

Physical review letters·1995
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with limited effective treatments. Current management focuses on symptom relief and supportive care via a multidisciplinary team approach.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disorder.
  • Despite over a century since its description, effective disease-modifying pharmacotherapies remain scarce.
  • Current treatments offer limited impact on the disease's natural progression.

Purpose of the Study:

  • To review the current therapeutic landscape for ALS.
  • To highlight the limitations of existing pharmacotherapies.
  • To emphasize the importance of multidisciplinary symptomatic management.

Main Methods:

  • Literature review of existing ALS pharmacotherapies.
  • Analysis of the efficacy of riluzole and recombinant human insulin-like growth factor (rhIGF-1).

Related Experiment Videos

  • Examination of current treatment paradigms for ALS.

    • Main Results:

    • Riluzole provides only marginal survival benefits without functional improvement.
    • The efficacy of rhIGF-1 in ALS treatment is still debated.
    • Symptomatic management through a multidisciplinary team is the primary treatment focus.

    Conclusions:

    • There is a critical unmet need for effective disease-modifying therapies for ALS.
    • Multidisciplinary care is essential for managing symptoms and improving quality of life in ALS patients.
    • Further research into novel therapeutic strategies is imperative for ALS treatment.